Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
159856-00-5
159855-98-8
2644-99-7
2645-02-5
4816-81-3
1080-44-0
70693-47-9 | 1-Disiloxanol,1,1,3,3,3-pentamethyl-, 1-acetate | AA00659H | MFCD00053702
992-78-9 | 1,4-Benzenediol, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl- | AA00662U | MFCD11973816
705949-01-5 | (1R,2R,3S,5R)-2-Amino-2,6,6-trimethyl-bicyclo[3.1.1]heptane-3-carboxylic acid methyl ester hydrochloride | AA0066WS | MFCD05863644
98519-65-4 | 4-Bromo-7-chloroquinoline | AA0067VP | MFCD07700232
722-56-5 | Diphenyliodonium nitrate | AA0068M0 | MFCD00031704
69648-38-0 | (R)-Butaprost | AA0069GJ | MFCD00867055
959238-35-8 | 1-(2-(Methylamino)ethyl)cyclopentanol | AA006A5H | MFCD09864405
944060-66-6 | 2-Chloro-8-methoxyquinazoline | AA006B0B | MFCD09907928
957060-94-5 | 5-Bromo-2-methoxypyridine-4-boronic acid | AA006BPM | MFCD07781223
90553-43-8 | 1-(5-Bromothiophen-2-yl)-N-methylmethanamine | AA006CLK | MFCD06379299